
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, synthesis and biological evaluation of dual Topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifs
Mengmiao Zhao, Kan Yang, Xinyue Zhu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115303-115303
Closed Access | Times Cited: 15
Mengmiao Zhao, Kan Yang, Xinyue Zhu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115303-115303
Closed Access | Times Cited: 15
Showing 15 citing articles:
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 15
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 15
Overview of the epigenetic/cytotoxic dual-target inhibitors for cancer therapy
Hailiu Liang, Shuqing Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117235-117235
Closed Access | Times Cited: 1
Hailiu Liang, Shuqing Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117235-117235
Closed Access | Times Cited: 1
Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers
Samar El‐Kalyoubi, Mohamed M. Khalifa, Mahmoud T. Abo‐Elfadl, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
Samar El‐Kalyoubi, Mohamed M. Khalifa, Mahmoud T. Abo‐Elfadl, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 18
A Concise Review on Recent Development of Indole Derivatives for Anticancer Activities
B. T. Sridhar, Nagesh Gunavanthrao Yernale, Ramesh S. Gani, et al.
Journal of the Indian Chemical Society (2024) Vol. 101, Iss. 10, pp. 101282-101282
Closed Access | Times Cited: 7
B. T. Sridhar, Nagesh Gunavanthrao Yernale, Ramesh S. Gani, et al.
Journal of the Indian Chemical Society (2024) Vol. 101, Iss. 10, pp. 101282-101282
Closed Access | Times Cited: 7
Nucleophile-Controlled Trapping of Gold Carbene by Nitriles and Water: Synthesis of 5H-Pyrimido[5,4-b]indoles and 2-Benzylidene-3-indolinones
Yunlong Zhu, Yifan Dong, Si-Ru Wang, et al.
Organic Letters (2024) Vol. 26, Iss. 3, pp. 631-635
Closed Access | Times Cited: 5
Yunlong Zhu, Yifan Dong, Si-Ru Wang, et al.
Organic Letters (2024) Vol. 26, Iss. 3, pp. 631-635
Closed Access | Times Cited: 5
Anticancer and antibacterial Activeness of fused Pyrimidines: Newfangled Updates
Ayushi Bhatnagar, Gangotri Pemawat
Bioorganic Chemistry (2024) Vol. 153, pp. 107780-107780
Closed Access | Times Cited: 4
Ayushi Bhatnagar, Gangotri Pemawat
Bioorganic Chemistry (2024) Vol. 153, pp. 107780-107780
Closed Access | Times Cited: 4
Unveiling the therapeutic potential: Evaluation of anti-inflammatory and antineoplastic activity of Magnolia champaca Linn’s stem bark isolate through molecular docking insights
Md Mahadi Hasan, Md. Tarikul Islam, Md. Sanowar Hossain, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e22972-e22972
Open Access | Times Cited: 9
Md Mahadi Hasan, Md. Tarikul Islam, Md. Sanowar Hossain, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e22972-e22972
Open Access | Times Cited: 9
New imidazole-2-thiones linked to acenaphythylenone as dual DNA intercalators and topoisomerase II inhibitors: structural optimization, docking, and apoptosis studies
Asmaa H. Mohamed, Mohammed B. Alshammari, Ashraf A. Aly, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Asmaa H. Mohamed, Mohammed B. Alshammari, Ashraf A. Aly, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 3
Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales
Andrey D. Bondarev, Jörgen Jönsson, Vladimir N. Chubarev, et al.
Pharmacological Research (2024) Vol. 209, pp. 107431-107431
Open Access | Times Cited: 3
Andrey D. Bondarev, Jörgen Jönsson, Vladimir N. Chubarev, et al.
Pharmacological Research (2024) Vol. 209, pp. 107431-107431
Open Access | Times Cited: 3
Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency
Yuan Jiang Pan, Haodong Hou, Bo Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115879-115879
Closed Access | Times Cited: 8
Yuan Jiang Pan, Haodong Hou, Bo Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115879-115879
Closed Access | Times Cited: 8
Recent developments of hydroxamic acid hybrids as potential anti-breast cancer agents
Xinran Cao, Yufeng Gong
Future Medicinal Chemistry (2024) Vol. 16, Iss. 5, pp. 469-492
Open Access | Times Cited: 2
Xinran Cao, Yufeng Gong
Future Medicinal Chemistry (2024) Vol. 16, Iss. 5, pp. 469-492
Open Access | Times Cited: 2
Identification of novel and potent dual-targeting HDAC1/SPOP inhibitors using structure-based virtual screening, molecular dynamics simulation and evaluation of in vitro and in vivo antitumor activity
Yingxue Yang, Shutong Chen, Qinghua Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Yingxue Yang, Shutong Chen, Qinghua Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Design, Synthesis and Anti‐Cancer Evaluation of Quinoline‐1,2,4‐triazine Hybrids
Chang‐E Dong, Cong Qi, Rui‐Li, et al.
ChemistrySelect (2024) Vol. 9, Iss. 33
Closed Access
Chang‐E Dong, Cong Qi, Rui‐Li, et al.
ChemistrySelect (2024) Vol. 9, Iss. 33
Closed Access
Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges
Anshul Mishra, Amandeep Thakur, Ram Lal Sharma, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 11, pp. 1355-1381
Closed Access
Anshul Mishra, Amandeep Thakur, Ram Lal Sharma, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 11, pp. 1355-1381
Closed Access
Cracking the Code: Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Birandra K. Sinha
(2023)
Open Access | Times Cited: 1
Birandra K. Sinha
(2023)
Open Access | Times Cited: 1